<?xml version="1.0" encoding="UTF-8"?>
<p id="par0120">Acetylcholinesterase (AChE) activities in the three regions of the brain was evaluated using the protocol documented by Ellman et al. [
 <xref rid="bib0160" ref-type="bibr">32</xref>]. The protein content of the homogenates was determined using BSA as a standard in the protocol described by Lowry et al. [
 <xref rid="bib0165" ref-type="bibr">33</xref>]. Nitric oxide (NO) level was assessed by procedure reported by Green et al. [
 <xref rid="bib0170" ref-type="bibr">34</xref>]. The concentration of dopamine was evaluated using procedure described by Guo et al. [
 <xref rid="bib0175" ref-type="bibr">35</xref>]. Myeloperoxidase (MPO) activity in the homogenate was quantified following the method of Granell et al. [
 <xref rid="bib0180" ref-type="bibr">36</xref>]. Lipid peroxidation was evaluated by monitoring the level of MDA using procedure reported by Varshney and Kale [
 <xref rid="bib0185" ref-type="bibr">37</xref>]. Superoxide dismutase (SOD) activity was evaluated following the inhibition of adrenaline auto-oxidation in a basic milieu as described by Misra and Fridovich, [
 <xref rid="bib0190" ref-type="bibr">38</xref>]. The reduced GSH content in the brain samples was determined using the protocol reported by Buetler et al. [
 <xref rid="bib0195" ref-type="bibr">39</xref>]. Hydrogen peroxide generation was assayed oxidation of ferrous ions and sorbitol colour amplification system using the method of Wolff, [
 <xref rid="bib0200" ref-type="bibr">40</xref>]. Catalase (CAT) activity was determined following the protocol documented by Clairborne [
 <xref rid="bib0205" ref-type="bibr">41</xref>] using hydrogen peroxide (H
 <sub>2</sub>O
 <sub>2</sub>) as a substrate.
</p>
